Evidence map›Paper›PMID 29430203›Full record

ReviewCanadian respiratory journal2017

Approach to Hemoptysis in the Modern Era.

Sébastien Gagnon, Nicholas Quigley, Hervé Dutau, Antoine Delage, Marc Fortin

Open access · goldAbstract readReview
In one paragraph

Review in Canadian respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Management of severe acute pulmonary haemorrhage in children.The Lancet. Child & adolescent health · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. An overview on the principles of management of haemoptysis.Indian journal of thoracic and cardiovascular surgery · 2023
    Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Bronchial Artery Embolization.Seminars in interventional radiology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sébastien GagnonInstitut Universitaire de Pneumologie et de Cardiologie de Québec, 2725 Ch Ste-Foy, Quebec City, QC, Canada G1V 4G5.ORCID 0000-0002-0579-4343
Nicholas QuigleyInstitut Universitaire de Pneumologie et de Cardiologie de Québec, 2725 Ch Ste-Foy, Quebec City, QC, Canada G1V 4G5.ORCID 0000-0001-9177-7947
Hervé DutauHôpital Nord Marseille, Assistance Publique des Hôpitaux de Marseille, 13915 Chemin des Bourrely, Marseille, France.ORCID 0000-0002-7726-2274
Antoine DelageInstitut Universitaire de Pneumologie et de Cardiologie de Québec, 2725 Ch Ste-Foy, Quebec City, QC, Canada G1V 4G5.
Marc FortinInstitut Universitaire de Pneumologie et de Cardiologie de Québec, 2725 Ch Ste-Foy, Quebec City, QC, Canada G1V 4G5.
Institut universitaire de cardiologie et de pneumologie de Québec · CAHôpital Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemoptysis is a frequent manifestation of a wide variety of diseases, with mild to life-threatening presentations. The diagnostic workup and the management of severe hemoptysis are often challenging. Advances in endoscopic techniques have led to different new therapeutic approaches. Cold saline, vasoconstrictive and antifibrinolytic agents, oxidized regenerated cellulose, biocompatible glue, laser photocoagulation, argon plasma coagulation, and endobronchial stents and valves are amongst the tools available to the bronchoscopist. In this article, we review the evidence regarding the definition, etiology, diagnostic modalities, and treatment of severe hemoptysis in the modern era with emphasis on bronchoscopic techniques.

Indexed as

AdhesivesAntifibrinolytic AgentsArgon Plasma CoagulationBiocompatible MaterialsBronchoscopyCelluloseCryotherapyHemoptysisHemostasis, SurgicalHumansLaser CoagulationStentsVasoconstrictor AgentsAdhesivesAntifibrinolytic AgentsBiocompatible MaterialsCelluloserayon, purifiedVasoconstrictor Agents

Identifiers

PMID29430203
PMCPMC5752991
OpenAlexW2777266300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.